China Shineway Pharmaceutical Group Limited (CSWYF)
USD 1.08
(7.57%)
USD 1.08
(7.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 140.61 Million | 178.55 Million | 120.14 Million | 102.24 Million | 65.02 Million | 93.57 Million |
| Net Income | 137.15 Million | 107.59 Million | 86.03 Million | 42.75 Million | 73.22 Million | 76.53 Million |
| Depreciation & Amortization | 8.52 Million | 8.73 Million | 9.83 Million | 7.12 Million | 7.76 Million | 6.18 Million |
| Deferred income taxes | - | - | -43.15 Million | -33.29 Million | - | - |
| Stock-based compensation | - | - | 5350.12 | 20.06 Thousand | 156.11 Thousand | - |
| Change in working capital | -13.24 Million | 43.16 Million | 6.67 Million | 5.51 Million | -34.47 Million | -9.12 Million |
| Other non-cash items | 75.41 Million | 19.06 Million | 60.71 Million | 80.01 Million | 62.54 Million | 53.99 Million |
| Investing Cash Flow | -16.05 Million | -17.21 Million | 2.97 Million | -13.05 Million | -3.99 Million | 47.04 Thousand |
| Investments in PPE | -20.41 Million | -19.27 Million | -14.47 Million | -9.56 Million | -13.3 Million | -21.14 Million |
| Acquisitions | 1.82 Million | 520.86 Thousand | 14.06 Million | -16.07 Million | 46.42 Thousand | 98.48 Thousand |
| Investment purchases | -73.56 Million | -44.65 Million | -57.18 Million | -361.56 Million | -130.97 Million | -62.9 Million |
| Sales/Maturities of investments | 75.05 Million | 45.65 Million | 58.58 Million | 368.06 Million | 136.28 Million | 71.18 Million |
| Other Investing Activities | 1.05 Million | 545.87 Thousand | 1.98 Million | 6.08 Million | 3.94 Million | 12.82 Million |
| Financing Cash Flow | -3.41 Million | -37.12 Million | -127.87 Million | -45.33 Million | -14.35 Million | -85.54 Million |
| Debt repayment | -42.44 Million | -1.11 Million | -57.07 Million | -4.21 Million | -57.97 Million | - |
| Dividends payments | -44.88 Million | -35.04 Million | -71.29 Million | -36.99 Million | -35.77 Million | -39.51 Million |
| Common Stock Repurchased | - | - | -1.19 Million | -5.28 Million | -35.51 Million | -46.02 Million |
| Common Stock Issuance | - | - | 566.09 Thousand | -36.43 Million | -244.01 Million | - |
| Other Financing Activities | 41.9 Million | -1.14 Million | -154.54 Thousand | 35.59 Million | -577.27 Thousand | - |
| Accounts receivables | -41.13 Million | -23.62 Million | -10.34 Million | -13.51 Million | -21.36 Million | -26.77 Thousand |
| Accounts payables | 24.9 Million | 11.92 Million | 8.55 Million | -3.63 Million | -3.44 Million | -2.67 Million |
| Inventory | -33.96 Million | -10.37 Million | -21.65 Million | -1.76 Million | -3.68 Million | -18.95 Million |
| Other working capital | 36.94 Million | 65.23 Million | 30.12 Million | 24.43 Million | -5.98 Million | 12.53 Million |
| Cash at beginning of period | 725.29 Million | 659.7 Million | 648.79 Million | 566.56 Million | 528.44 Million | 549.1 Million |
| Cash at end of period | 830.09 Million | 725.29 Million | 659.7 Million | 648.79 Million | 566.56 Million | 528.44 Million |
| Capital Expenditure | -20.41 Million | -19.27 Million | -14.47 Million | -9.56 Million | -13.3 Million | -21.14 Million |
| Effect of forex changes on cash | 6.15 Million | 6.32 Million | -6.51 Million | -6.18 Million | -0.33 | - |
| Net cash flow / Change in cash | 104.8 Million | 65.58 Million | 10.9 Million | 82.22 Million | 38.11 Million | -20.65 Million |
| Free Cash Flow | 120.2 Million | 159.28 Million | 105.67 Million | 92.68 Million | 51.72 Million | 72.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 43.1 Million | 43.38 Million | 137.15 Million | 33.67 Million | 32.73 Million | 70.9 Million |
| Depreciation & Amortization | 5.55 Million | 5.58 Million | 8.52 Million | 6.41 Million | 6.23 Million | 12.42 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -13.24 Million | -11.84 Million | -11.51 Million | - |
| Other non-cash items | -9.84 Million | -9.9 Million | 75.41 Million | 14.81 Million | 14.4 Million | -8.79 Million |
| Investing Cash Flow | 5.47 Million | 5.51 Million | -16.05 Million | 257.33 Thousand | 250.17 Thousand | -11.02 Million |
| Investments in PPE | -5.12 Million | -5.15 Million | -20.41 Million | -6.7 Million | -6.51 Million | -16.65 Million |
| Acquisitions | 360.02 Thousand | - | 1.82 Million | 335.32 Thousand | - | 1.44 Million |
| Investment purchases | -104.05 Million | - | -73.56 Million | -42.96 Million | - | -28.85 Million |
| Sales/Maturities of investments | 107.46 Million | - | 75.05 Million | 40.89 Million | - | 32.36 Million |
| Other Investing Activities | 10.6 Million | 10.67 Million | 1.05 Million | 6.96 Million | 6.76 Million | 679.82 Thousand |
| Financing Cash Flow | -20.75 Million | -20.89 Million | -3.41 Million | -6.28 Million | -6.1 Million | 9.03 Million |
| Debt repayment | -4.16 Million | - | -42.44 Million | -1.94 Million | - | -43.28 Million |
| Dividends payments | -45.06 Million | -22.49 Million | -44.88 Million | -5.85 Million | -5.69 Million | -33.78 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.58 Million | 1.59 Million | 41.9 Million | -431.4 Thousand | -419.39 Thousand | 20.44 Million |
| Accounts receivables | - | - | -41.13 Million | -20.48 Million | -19.91 Million | - |
| Accounts payables | - | - | 24.9 Million | - | - | - |
| Inventory | - | - | -33.96 Million | -16.91 Million | -16.43 Million | - |
| Other working capital | - | - | 36.94 Million | 25.54 Million | 24.83 Million | - |
| Cash at beginning of period | 830.09 Million | - | 725.29 Million | 738.29 Million | - | 725.29 Million |
| Cash at end of period | 857.73 Million | 23.97 Million | 830.09 Million | 830.09 Million | 35.89 Million | 738.29 Million |
| Capital Expenditure | -5.12 Million | -5.15 Million | -20.41 Million | -6.7 Million | -6.51 Million | -16.65 Million |
| Effect of forex changes on cash | 291.16 Thousand | 293.05 Thousand | 6.15 Million | -104.89 Thousand | -101.97 Thousand | 526.68 Thousand |
| Net cash flow / Change in cash | 27.64 Million | 23.97 Million | 104.8 Million | 91.79 Million | 35.89 Million | 13 Million |
| Free Cash Flow | 33.68 Million | 33.9 Million | 120.2 Million | 36.35 Million | 35.34 Million | 33.03 Million |
600869
AMST
SPQDF
API
BCNAY
300652